International Journal of Infectious Diseases (Sep 2022)

Use of broad-spectrum antibiotics in children diagnosed with multisystem inflammatory syndrome temporarily associated with SARS-CoV-2 infection in Poland: the MOIS-CoR study

  • Kacper Toczyłowski,
  • Joanna Łasecka-Zadrożna,
  • Ilona Pałyga-Bysiecka,
  • Kamila Maria Ludwikowska,
  • Magdalena Okarska-Napierała,
  • Natalia Dudek,
  • Aneta Afelt,
  • Catherine Suski,
  • Miron Bartosz Kursa,
  • Teresa Jackowska,
  • Ernest Kuchar,
  • Leszek Szenborn,
  • Katarzyna Mazur-Melewska,
  • Marta Barszcz,
  • Elżbieta BerdejSzczot,
  • Sebastian Brzuszkiewicz,
  • Piotr Buda,
  • Alicja Czajka,
  • Agnieszka Czech,
  • Ewa Czerwińska,
  • Magdalena Figlerowicz,
  • Małgorzata FirekPędras,
  • Aneta Gawlik,
  • Ewelina Gowin,
  • Olga Izdebska,
  • Danuta JanuszkiewiczLewandowska,
  • Justyna Kiepuszka,
  • Agnieszka Koczwara,
  • Danuta Koszałko,
  • Magdalena KośmiderŻurawska,
  • Janusz Książyk,
  • Beata Kucińska,
  • Martyna Kukawska,
  • Anita Lackowska,
  • Katarzyna Łapacz,
  • Agnieszka Maliszak,
  • Anna Mania,
  • Joanna Mańdziuk,
  • Artur Mazur,
  • Cezary Niszczota,
  • Paulina OpalińskaZielonka,
  • Katarzyna Rojewska,
  • Anna RożnowskaWójtowicz,
  • Bartosz Siewert,
  • Paulina Sobiczewska,
  • Lidia Stopyra,
  • Agnieszka StrobaŻelek,
  • Joanna StryczyńskaKazubska,
  • Tomasz Szatkowski,
  • Barbara Szczepańska,
  • Maciej Szczukocki,
  • Robert Szylo,
  • Filip Tyc,
  • Katarzyna Wielgos,
  • Ewa Wołowska,
  • Jacek Wysocki,
  • Anna Zacharzewska,
  • Marcin Zaniew,
  • Marzena Zielińska,
  • Katarzyna ZiębaGlonek

Journal volume & issue
Vol. 122
pp. 703 – 709

Abstract

Read online

Objectives: Multisystem inflammatory syndrome in children (MIS-C) is the result of an immune response triggered by a previous exposure to SARS-CoV-2. The clinical presentation of MIS-C overlaps with other life-threatening bacterial infections, in which antimicrobials are the mainstay therapy. The aim of study was to describe the use of antibiotics in children with MIS-C in Poland. Methods: The analysis of 345 children reported from 42 Polish cities to the national MultiOrgan Inflammatory Syndromes COVID-19 Related Study (MOIS-CoR Study) from June 2020 to April 2021. Results: At least one antibiotic was used in 310 (90%) children, mainly third-generation cephalosporin (251/310). Broad-spectrum antibiotics were used in 258 (75%) children and 224 (87%) received this treatment for more than 3 days. Concentrations of serum procalcitonin >2 µg/l and the presence of lower respiratory symptoms were associated with increased odds of receiving any antibiotic. Conclusion: Although bacterial infections in patients with MIS-C are uncommon, we show that MIS-C poses a challenge to clinicians who are faced with the decision to start, continue, or stop antimicrobial therapy. Antibiotic stewardship in patients with MIS-C should be improved to ensure that likely pathogens are treated and that antimicrobials are stopped when bacterial infections are excluded and the diagnosis of MIS-C is made.

Keywords